awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q35906490-7A905B05-AE22-47FA-A7B3-D7E8F9E56ADB
Q35906490-7A905B05-AE22-47FA-A7B3-D7E8F9E56ADB
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35906490-7A905B05-AE22-47FA-A7B3-D7E8F9E56ADB
SGLT-2 Inhibitors: A New Mechanism for Glycemic Control.
P2860
Q35906490-7A905B05-AE22-47FA-A7B3-D7E8F9E56ADB
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35906490-7A905B05-AE22-47FA-A7B3-D7E8F9E56ADB
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
1831fcf81f3c1e217fd2deabd1c3f0384f1bc54f
P2860
Dapagliflozin monotherapy in type 2 diabetic patients with inadequate glycemic control by diet and exercise: a randomized, double-blind, placebo-controlled, phase 3 trial.